SpringWorks Therapeutics, Inc. announced the appointment of Francis (Frank) Perier, Jr. as Chief Financial Officer (CFO). Mr. Perier previously served as the CFO of Forest Laboratories, Inc. for ten years, prior to its acquisition by Actavis in 2014. He was the Executive Vice President of Finance and during his tenure had the experience of leading the finance, human resources and legal functions. Prior to joining Forest, Mr. Perier was with Bristol-Myers Squibb Company for approximately nine years, where he worked in corporate and operations finance capacities of increasing responsibilities, including Vice President of Finance and Operations Planning - Americas Medicines Group, the company’s largest business unit at that time. Before joining Bristol-Myers Squibb, he was an accounting and auditing partner at Deloitte, where he worked for about 15 years. Mr. Perier was a member of the Board of Directors of Concordia International, Inc., a specialty pharmaceutical company, until September 2018 where he served on the Audit and the Human Resources and Compensation Committees of the Company.